NCT03477708View on ClinicalTrials.gov

The Impact of Continuous Transcutaneous CO2 (TCCO2) Monitoring in Extremely Low Birth Weight (ELBW) Infants

CompletedOBSERVATIONAL

Enrollment

166

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

April 1, 2022

Study Completion Date

April 1, 2022

Conditions

ELBW - Extremely Low Birth Weight InfantIVH- Intraventricular Hemorrhage

Trial Locations (1)

Unknown

Rambam Medical Center, Haifa

All Listed Sponsors

lead

Rambam Health Care Campus

OTHER

NCT03477708 - The Impact of Continuous Transcutaneous CO2 (TCCO2) Monitoring in Extremely Low Birth Weight (ELBW) Infants | Biotech Hunter | Biotech Hunter